Met Non Small Cell Cancer Registry (MOMENT)
Recruiting
700 enrolled
PROVIDENCE
Recruiting
132 enrolled
CLEAR
Terminated
14 enrolled
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Recruiting
500 enrolled
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Enrolling by invitation
500 enrolled
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Recruiting
200 enrolled
Polaris
Active not recruiting
10,000 enrolled
OVAmiARN
Active not recruiting
746 enrolled
SIMA
Recruiting
3,195 enrolled
Development and Application of Patient-Derived Models of Cancer
Enrolling by invitation
40 enrolled
OPAL
Active not recruiting
537 enrolled
VICTORIE
Active not recruiting
1 enrolled
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
Recruiting
377 enrolled
PROCARES
Recruiting
1,650 enrolled
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
Recruiting
60 enrolled
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Recruiting
500 enrolled
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
Completed
131 enrolled
REALNESS
Completed
204 enrolled
BASECAMP-1
Recruiting
200 enrolled
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
Enrolling by invitation
60 enrolled
GEMINI-NSCLC: NSCLC Biomarker Study
Recruiting
1,200 enrolled
AB1MALT
Active not recruiting
35 enrolled
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Active not recruiting
1,000 enrolled
SAPHIR
Recruiting
1,900 enrolled
Caris Biorepository Research Protocol
Recruiting
100,000 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
Completed
49 enrolled
FOREFRONT
Active not recruiting
532 enrolled
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Recruiting
330 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Comprehensive Segmental Revision System
Active not recruiting
105 enrolled
VALOR
Completed
120 enrolled
VeRVe
Recruiting
500 enrolled
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Completed
140,706 enrolled
DANBIO
Completed
38,396 enrolled
PETRiS
Recruiting
850 enrolled
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
Completed
14 enrolled
LIVEN
Active not recruiting
210 enrolled
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
Completed
150 enrolled
REFLECTION: A Clinical Practice Learning Program for Galleri®
Active not recruiting
14,633 enrolled
Real World Registry for Use of the Ion Endoluminal System
Recruiting
3,000 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Recruiting
20,000 enrolled
Post-Marketing Surveillance Study of OTEZLA
Completed
1,086 enrolled
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
Completed
7,435 enrolled
PREMIER
Recruiting
500 enrolled
Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Completed
368 enrolled
ESVECO
Recruiting
70 enrolled